Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimagrumab in COPD Patients With Cachexia
NCT01669174Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2012
- Primary completion
- Dec 2014
- Countries
- 3
01
Overview
A Phase 2 trial of bimagrumab in chronic obstructive pulmonary disease (COPD), cachexia, sponsored by Novartis. Started Sep 2012; status: completed.
02
Drugs
bimagrumab
03
Conditions
chronic obstructive pulmonary disease (COPD)cachexia
Beyond the preview
Go deeper on NCT01669174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01669174.